• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

SushiSwap Announces Plans for Expansion and Development

user avatar

by Giorgi Kostiuk

a year ago


SushiSwap, a leading decentralized finance (DeFi) platform, has unveiled a bold roadmap for 2025. CEO Jared Grey announced several new initiatives designed to diversify and expand the platform's offerings.

Expanding with Solana: The Wara Project

One of SushiSwap's ambitious plans includes Wara, a comprehensive trading platform built on Solana. By expanding beyond Ethereum Virtual Machine (EVM) networks, SushiSwap aims to tap into the growing Solana ecosystem. The integration of Solana is part of a broader strategy to franchise the SushiSwap brand and product stack into new ecosystems.

Susa: A New On-Chain Order Book DEX

The Susa project is a new perpetual decentralized exchange with an on-chain order book. Built on the N1 network, known for its high performance, Susa aims to provide a more efficient and transparent way for users to trade perpetual contracts.

Kubo and Blade: Enhancing Market Creation and Liquidity

SushiSwap is also introducing Kubo, a new tool to launch markets with delta-neutral strategies designed to minimize exposure to price volatility. Additionally, Blade, an innovative LVR automated market maker solution, is designed to eliminate miner extractable value (MEV) for blue-chip assets.

SushiSwap is actively working on expanding and diversifying its offerings, as well as planning a treasury strategy shift. These initiatives aim to enhance liquidity and create a more sustainable DeFi environment.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Converge Bio's AI Platform Aims to Transform Drug Development

chest

Converge Bio is leveraging its newly acquired $25 million funding to enhance its AI platform, which focuses on drastically reducing the time and costs associated with drug development.

user avatarKenji Takahashi

Converge Bio Secures $25 Million Series A Funding to Transform Drug Discovery

chest

Converge Bio, a startup based in Boston and Tel Aviv, has raised $25 million in Series A funding to enhance AI-driven drug discovery.

user avatarMaria Fernandez

Buterin Continues Charity Donations from Token Sales

chest

Vitalik Buterin continues his practice of selling unsolicited tokens and donating the proceeds to charity, emphasizing ethical considerations in cryptocurrency promotions.

user avatarRajesh Kumar

Vitalik Buterin Sells Unsolicited Tokens for 94 ETH

chest

Ethereum cofounder Vitalik Buterin has sold unsolicited tokens from his wallet, converting them into 94 ETH.

user avatarGustavo Mendoza

Grayscale Segments Crypto Market into Five Vertical Categories

chest

Grayscale has categorized its altcoin candidates into five verticals, reflecting a structured approach to the crypto market.

user avatarMiguel Rodriguez

Decline in FLOW Price Amid Controversial Asset Recovery

chest

The price of FLOW has seen a significant decline following the Flow project's controversial asset recovery actions.

user avatarLuis Flores

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.